You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 3838 results
  1. Developing Versatile and Facile Chemical Synthesis Methodologies for Preparation of 18F-Tracers for PET Imaging

    SBC: TheraCea Pharma LC            Topic: NIBIB

    Project Summary/Abstract Positron emission tomography (PET) is an exquisitely sensitive and quantitative imaging modality with numerous applications in oncology, neuroimaging, infection/inflammation, and cardiology. PET has great potential for hybrid imaging techniques in which nuclear medicine can be combined with anatomic imaging techniques such as magnetic resonance imaging (MRI). Such approach ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  2. An Interoperable HL7 FHIR-based Medical Device Data System (MDDS) For Accessing And Integrating Live Point-Of-Care Data From High-Acuity Bedside Patient Monitoring Equipment

    SBC: MEDICOLLECTOR LLC            Topic: NIBIB

    Abstract The overall goal of this proposal is to combine expertise and approaches from biomedical engineering and critical care medicine to design a universal system to acquire, record and transmit physiological signals from bedside monitored patients. Patient monitors generate over a million datapoints of information per hour, however, only a tiny fraction of those data are transmitted or recorde ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  3. Preclinical development of a Stathmin-2 splicing modulator for ALS

    SBC: Quralis Corporation            Topic: 999

    PROJECT SUMMARY ALS is a devastating neurodegenerative disease with two FDA-approved therapies that can prolong a patient’s lifespan by only a few months. Thus, an effective therapeutic to treat ALS is needed. ALS can arise sporadically or through inherited mutations in one or a combination of several genes. The heterogeneity of ALS makes it difficult to create a therapeutic that can effectively ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  4. Neurosurgical Planning with Robust Eloquent area Delineation from Individualized Connectivity-based Techniques (NeuroPREDICT)

    SBC: CHARLES RIVER ANALYTICS, INC.            Topic: 999

    Project Summary/AbstractThe idiosyncrasies of the human brain require that individualized mapping of functional regions be performed before surgical interventions for cancer or epilepsy. The success of this mapping procedure has direct effects on surgical outcomes and preserving cognitive and sensory function post-surgery. Current gold standard procedures for pre-surgical mapping are invasive, tim ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  5. Discover HTT-lowering small-molecule drugs to treat Huntington's disease

    SBC: RGENTA THERAPEUTICS LLC            Topic: 999

    ABSTRACT Rgenta has developed a robust, innovative, target and lead discovery platform that has identified small molecules that can lower the levels of HTT through a novel mechanism-of-action in RNA-targeting. In this Phase I SBIR project, we aim to develop first-in-class drug candidate compounds for HTT lowering as a new therapeutic approach for treating HD. Our Phase I SBIR proposal has three ai ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  6. SBIR Phase I: An Injectable Treatment for the Repair of Damaged Tendons and Ligaments

    SBC: RegenX LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop safe and affordable COVID-19 vaccination technology, with broader utility in preventing other types of outbreak in the future. This nov

    SBIR Phase I 2020 National Science Foundation
  7. Novel Therapeutic Agents to Reverse Opioid Overdose

    SBC: Clear Scientific, LLC            Topic: NIDA

    Project Summary/Abstract The abuse of opioids is a serious national crisis that affects public health as well as social and economic welfare. A 2018 report from the Centers for Disease Control and Prevention (CDC) shows that every day, 128 people in the United States die from opioid overdose. Synthetic opioids (e.g. fentanyl) have become the leading cause of drug-related deaths in recent years. Th ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  8. "Wearable sensor for opioids detection based on electrochemical sensor array integrated with Bluetooth device "

    SBC: EMITECH, INC.            Topic: NIDA

    Project Summary/Abstract Wearable sensor for opioids detection based on electrochemical sensor arrayintegrated with Bluetooth deviceIn this Phase I project, we will develop the prototype of a wearable device, as a forearm bracelet, for rapid, on-site opioid intake monitoring and alerting. We will demonstrate the feasibility of this approach by fabricating an electrochemical sensor array, sweat sti ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  9. Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women

    SBC: ISA ASSOCIATES INC            Topic: 102

    PROJECT SUMMARY/ABSTRACTAfrican American women are almost twice as likely to be diagnosed with cervical cancer (CC) as white women. Their initial clinical picture is also more negative, characterized by more severe dysplastic changes and later-stage disease. Given this, it is not surprising that Black women are also more than twice as likely to die from CC as compared to white women. Even worse, t ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  10. Torque Sensing Fastener

    SBC: Armorworks Enterprises, Inc.            Topic: N202100

    SBIR Phase I proposal to demonstrate non-contact,non-destructive in-situ torque and fastener preload measurement for threaded fasteners such as nuts, bolts, and screws.  Conventional NAS and SAE fasteners are used to demonstrate torque and preload sensing methods.  Results are compared and validated with conventional torque wrench measurement, ultrasonic bolt elongation measurements, and cross-c ...

    SBIR Phase I 2020 Department of DefenseNavy
US Flag An Official Website of the United States Government